Microbiome and disease associations: Cause or consequence? - Dr. Sabine Hazan

Understand the value of genetic sequencing in fecal transplants and in SARS-CoV-2 therapies. The microbiome is changing the way we look at healthcare, 100 trillion bacterial cells in our guts hold many answers.

Watch Dr. Sabine Hazan's "Microbiome and disease associations: Cause or consequence?" during the Malibu Microbiome Meeting (March 20, 2021).

Dr. Sabine Hazan is a physician, specialist in gastroenterology, internal medicine and hepatology. She’s the CEO of Progenabiome and Ventura Clinical Trials, and the co-founder of Topelia Therapeutics. As the founder& CEO of Progenabiome and Ventura Clinical Trials she has 20+ years of experience conducting cutting-edge research, currently with 35+ studies investigating the role of the gut flora in connection to various medical issues, including Autism, Psoriasis, Rheumatoid Arthritis and COVID-19, among many others (see link to studies below).

Since March 2020, Dr. Hazan has been at the forefront of the COVID-19 research, leading ongoing FDA-approved clinical trials for treatment and prophylaxis. Through their study exploring the role of the gut flora in COVID-19, Progenabiome became the first lab worldwide to detectSARS-CoV-2 from patient fecal samples by Whole Genome Sequencing.

#AutismIsMedical #AutismIsTreatable #AutismIsPreventable #1in54 #AutismPandemic